Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes

TheMotleyFool

0 0

The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes

Although Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine is no longer on pause, the healthcare giant still faces some major production challenges. In this Motley Fool Live video recorded on April 21, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the biggest loser with J&J's COVID-19 vaccine manufacturing woes.

Source Fool.com

Like: 0

EBS

Share